3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
3
Gastrointestinal
2
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
20
Sleep Initiation and Maintenance Disorders
6
Anxiety Disorders
4
Prostatic Neoplasms
3
Weight Loss
2
Overweight
2
Obesity
2
Motor Activity
2
Melanoma
2
Lung Neoplasms
2
Depression
2
Colorectal Neoplasms
2
Weight Gain
1
Uterine Cervical Neoplasms
1
Smoking Cessation
1
Pain, Postoperative
1
Ovarian Neoplasms
1
Neoplasms
1
Medication Adherence
1
Inflammation
1
Genetic Predisposition to Disease
1
Gastrointestinal Neoplasms
1
Fanconi Anemia, Complementation Group D1
1
Colonic Neoplasms
1
Cognitive Dysfunction
1
Chronic Pain
1
Interventions
pembrolizumab
42
Paclitaxel
26
Cyclophosphamide
25
Carboplatin
23
olaparib
21
Nivolumab
16
fludarabine
15
Docetaxel
13
aldesleukin
12
Gemcitabine
11
Fulvestrant
11
veliparib
9
Bevacizumab
9
sargramostim
8
palbociclib
8
durvalumab
8
Trastuzumab
8
Magnetic Resonance Spectroscopy
8
liposomal doxorubicin
7
atezolizumab
7
Surveys and Questionnaires
7
Ipilimumab
7
Blood Specimen Collection
7
niraparib
6
avelumab
6
Taxes
6
Specimen Handling
6
Interleukin-2
6
Fluorouracil
6
Cisplatin
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Cognitive Behavioral Therapy
×
Breast
×
Clear all
NCT03889171
2019-03-28
PSICOM
University Hospital, Montpellier
Completed
200 enrolled